Director/PDMR Shareholding

RNS Number : 7791Y

Dechra Pharmaceuticals PLC

07 March 2017

 

7 March 2017

Dechra Pharmaceuticals PLC

(the Company)

Director Shareholding

The Company announces that on 7 March 2017 Richard Cotton, Chief Financial Officer, was granted the following awards over ordinary shares of 1 pence each in the Company.  Each award will vest, subject to the satisfaction of a performance condition, on the date specified below:

Type of award	Number of shares subject to award	Vesting date
Nil cost option	21,033	3 January 2018
Nil cost option	21,033	15 September 2018

These are the recruitment awards referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2016.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Richard Cotton
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	N/A
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Grant of nil cost options
c)	Price(s) and volumes(s)	Price(s) Nil cost Nil cost	Volume(s) 21,033 21,033
d)	Aggregated information -   Aggregate volume -   Price	N/A
e)	Date of the transaction	2017.03.07
f)	Place of the transaction	Outside a trading venue

For further information, please contact:

Suzana Cross, Company Secretary           

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHOKODDPBKDANK